Login
EN
[EN] English
[FR] Français
Login
EN
[EN] English
[FR] Français
Explore
Search
Special collections
Statistics
News
Help
Start on ORBi
Deposit
Profile
Publication List
Add your ORCID
FAQ: FWB Open Access Decree
Tutorials
Legal Information
Training sessions
About
What's ORBi ?
Impact and visibility
Around ORBi
About statistics
About metrics
OAI-PMH
ORBi team
Release Notes
Back
Home
L’hémorragie alvéolaire diffuse : complication rare et impressionnante du traitement par Alemtuzumab (cas clinique SEP) - 2022
Download
Poster (Scientific congresses and symposiums)
L’hémorragie alvéolaire diffuse : complication rare et impressionnante du traitement par Alemtuzumab (cas clinique SEP)
Dauby, Solène
2022
•
JNLF congress 2022
Peer reviewed
Permalink
https://hdl.handle.net/2268/346539
Files (1)
Send to
Details
Statistics
Bibliography
Similar publications
Files
Full Text
JNLF2022_DAH_sur_LEM_SD.pdf
Author postprint (2.53 MB)
Download
All documents in ORBi are protected by a
user license
.
Send to
RIS
BibTex
APA
Chicago
Permalink
X
Linkedin
copy to clipboard
copied
Details
Disciplines :
Neurology
Author, co-author :
Dauby, Solène
;
Université de Liège - ULiège > GIGA
Language :
French
Title :
L’hémorragie alvéolaire diffuse : complication rare et impressionnante du traitement par Alemtuzumab (cas clinique SEP)
Publication date :
2022
Event name :
JNLF congress 2022
Event place :
Strasbourg, France
Event date :
12/04/2022
Audience :
International
Peer review/Selection committee :
Peer reviewed
Available on ORBi :
since 29 June 2026
Statistics
Number of views
30 (1 by ULiège)
Number of downloads
9 (0 by ULiège)
More statistics
Bibliography
Similar publications
Contact ORBi